Showing results (981-990 of 3,790) with videos related to
Sort By:
Pageof 379
Oncoimmunology|May 8, 2015
Kynurenine and uric acid levels in chronic myeloid leukemia patientsVladimir Vonka, Zuzana Humlova, Hana Klamova, et al.Oncoimmunology|May 8, 2015
Controlling T cell senescence in the tumor microenvironment for tumor immunotherapyJian Ye, Guangyong PengOncoimmunology|May 8, 2015
Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in miceSimon Gebremeskel, Daniel R Clattenburg, Drew Slauenwhite, et al.Oncoimmunology|May 9, 2015
Healing after death: antitumor immunity induced by oncolytic adenoviral therapyHong Jiang, Juan FueyoOncoimmunology|May 6, 2015
Trial watch: IDO inhibitors in cancer therapyErika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.Oncoimmunology|May 6, 2015
Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8+ T-cell response, prominent infiltration of CD8+ lymphocytes and Th1 type polarizationTuuli Ranki, Timo Joensuu, Elke Jäger, et al.Oncoimmunology|May 6, 2015
Unleashing antitumor T-cell activation without ensuing autoimmunity: the case for A20-deletion in adoptive CD8+ T-cell therapyGrégory Verdeil, Anne-Marie Schmitt-VerhulstOncoimmunology|May 6, 2015
Alarmins released during local antitumor treatments play an essential role in enhancing tumor growth inhibition at treated and non-treated sites via a derivative of CCL3Shiro Kanegasaki, Tomoko TsuchiyaOncoimmunology|May 6, 2015
IGF-1R peptide vaccines/mimics inhibit the growth of BxPC3 and JIMT-1 cancer cells and exhibit synergistic antitumor effects with HER-1 and HER-2 peptidesKevin Chu Foy, Megan J Miller, Jay Overholser, et al.Pageof 379